News & Views
Scientists identify the best post-transplant drug combination
Jul 29 2011
Researchers from the University of Miami, in collaboration with the American Society of Nephrology, found that, following a multi-year study, the combination of two immunosuppressive drugs led to fewer instances of organ rejection and better health after transplant.
Medication following a transplant is a delicate balancing act as immunosuppressant drugs are essential for the acceptance of the new organ but can result in a weaker immune system, leaving the patient open to greater risk of infection, cancer and other risks.
In a study of 150 kidney transplant patients, the scientists found that using tacrolimus and mycophenolate mofetil (MMF) in combination provided the best long-term benefits and fewest side effects.
"We have been able to prove that the use of low-dose tacrolimus and MMF is safe and provides excellent outcomes over time to renal transplant patients," said Dr Giselle Guerra, lead author of the study.
Digital Edition
Lab Asia 31.2 April 2024
April 2024
In This Edition Chromatography Articles - Approaches to troubleshooting an SPE method for the analysis of oligonucleotides (pt i) - High-precision liquid flow processes demand full fluidic c...
View all digital editions
Events
May 05 2024 Seville, Spain
InformEx Zone at CPhl North America
May 07 2024 Pennsylvania, PA, USA
May 14 2024 Oklahoma City, OK, USA
May 15 2024 Birmingham, UK
May 21 2024 Lagos, Nigeria